CN104995181B - 沃替西汀生产方法 - Google Patents
沃替西汀生产方法 Download PDFInfo
- Publication number
- CN104995181B CN104995181B CN201480009227.0A CN201480009227A CN104995181B CN 104995181 B CN104995181 B CN 104995181B CN 201480009227 A CN201480009227 A CN 201480009227A CN 104995181 B CN104995181 B CN 104995181B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- piperazine
- equivalents
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300104 | 2013-02-22 | ||
| DKPA201300104 | 2013-02-22 | ||
| PCT/EP2014/053313 WO2014128207A1 (en) | 2013-02-22 | 2014-02-20 | Vortioxetine manufacturing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104995181A CN104995181A (zh) | 2015-10-21 |
| CN104995181B true CN104995181B (zh) | 2017-03-08 |
Family
ID=59215387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480009227.0A Active CN104995181B (zh) | 2013-02-22 | 2014-02-20 | 沃替西汀生产方法 |
Country Status (37)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2879314T3 (es) | 2010-08-18 | 2021-11-22 | Biosplice Therapeutics Inc | Dicetonas e hidroxicetonas como activadores de la vía de señalización de catenina |
| RU2019104082A (ru) | 2013-02-22 | 2019-04-10 | СЭМЬЮМЕД, ЭлЭлСи | γ-ДИКЕТОНЫ В КАЧЕСТВЕ АКТИВАТОРОВ WNT/β -КАТЕНИНОВОГО СИГНАЛЬНОГО ПУТИ |
| MX368248B (es) | 2014-08-20 | 2019-09-25 | Samumed Llc | Gamma-dicetonas para tratamiento y prevencion de piel envejecida y arrugas. |
| WO2016125191A2 (en) | 2015-02-04 | 2016-08-11 | Mylan Laboratories Limited | Processes for the preparation of vortioxetine hydrobromide |
| WO2016151328A1 (en) | 2015-03-26 | 2016-09-29 | Cipla Limited | Method for making serotonin reuptake inhibitors |
| CN106279065A (zh) * | 2015-05-12 | 2017-01-04 | 北京深蓝海生物医药科技有限公司 | 一种氢溴酸沃替西汀的精制转晶方法 |
| JO3456B1 (ar) | 2015-05-13 | 2020-07-05 | H Lundbeck As | فيروتيوكسيتين بيروجلوتامات |
| EP3414216B1 (en) * | 2016-02-08 | 2020-10-21 | AAA Chemistry ApS | Arylation of aliphatic amines |
| WO2018002115A1 (en) | 2016-07-01 | 2018-01-04 | H. Lundbeck A/S | Vortioxetine dosing regimes for fast onset of antidepressant effect |
| US10519121B2 (en) | 2016-12-30 | 2019-12-31 | Apicore Us Llc | Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
| CN109912538B (zh) * | 2019-01-22 | 2021-03-12 | 安徽赛乐普制药有限公司 | 一种抗抑郁药沃替西汀的制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1561336A (zh) * | 2001-10-04 | 2005-01-05 | H·隆德贝克有限公司 | 作为血清素再摄取抑制剂的苯基哌嗪衍生物 |
| WO2007144005A1 (en) * | 2006-06-16 | 2007-12-21 | H. Lundbeck A/S | 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| WO2010094285A1 (en) * | 2009-02-17 | 2010-08-26 | H. Lundbeck A/S | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003053942A1 (en) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Aryloxyphenyl and arylsulfanylphenyl derivatives |
-
2014
- 2014-02-20 DK DK14705524.8T patent/DK2958903T3/en active
- 2014-02-20 ES ES14705524.8T patent/ES2625380T3/es active Active
- 2014-02-20 AP AP2015008640A patent/AP2015008640A0/xx unknown
- 2014-02-20 CN CN201480009227.0A patent/CN104995181B/zh active Active
- 2014-02-20 JP JP2015558446A patent/JP6464098B2/ja active Active
- 2014-02-20 US US14/767,350 patent/US9353073B2/en active Active
- 2014-02-20 PL PL14705524T patent/PL2958903T3/pl unknown
- 2014-02-20 LT LTEP14705524.8T patent/LT2958903T/lt unknown
- 2014-02-20 MX MX2015010656A patent/MX362355B/es active IP Right Grant
- 2014-02-20 EP EP14705524.8A patent/EP2958903B1/en active Active
- 2014-02-20 RU RU2015134407A patent/RU2652265C2/ru active
- 2014-02-20 RS RS20170399A patent/RS55932B1/sr unknown
- 2014-02-20 PT PT147055248T patent/PT2958903T/pt unknown
- 2014-02-20 SG SG11201506651SA patent/SG11201506651SA/en unknown
- 2014-02-20 WO PCT/EP2014/053313 patent/WO2014128207A1/en not_active Ceased
- 2014-02-20 PE PE2015001720A patent/PE20151589A1/es active IP Right Grant
- 2014-02-20 UA UAA201509642A patent/UA116236C2/uk unknown
- 2014-02-20 KR KR1020157021985A patent/KR102230628B1/ko active Active
- 2014-02-20 MY MYPI2015002072A patent/MY172337A/en unknown
- 2014-02-20 HR HRP20170607TT patent/HRP20170607T1/hr unknown
- 2014-02-20 EA EA201591349A patent/EA027756B1/ru not_active IP Right Cessation
- 2014-02-20 GE GEAP201413919A patent/GEP201706749B/en unknown
- 2014-02-20 MA MA38338A patent/MA38338B1/fr unknown
- 2014-02-20 AU AU2014220735A patent/AU2014220735B2/en active Active
- 2014-02-20 SI SI201430214T patent/SI2958903T1/sl unknown
- 2014-02-20 ME MEP-2017-91A patent/ME02671B/me unknown
- 2014-02-20 SM SM20170238T patent/SMT201700238T1/it unknown
- 2014-02-20 CA CA2901821A patent/CA2901821A1/en not_active Abandoned
- 2014-02-20 BR BR112015019268-8A patent/BR112015019268B1/pt active IP Right Grant
-
2015
- 2015-08-06 TN TN2015000335A patent/TN2015000335A1/en unknown
- 2015-08-10 DO DO2015000187A patent/DOP2015000187A/es unknown
- 2015-08-11 IL IL240501A patent/IL240501B/en active IP Right Grant
- 2015-08-17 PH PH12015501807A patent/PH12015501807B1/en unknown
- 2015-08-18 CR CR20150423A patent/CR20150423A/es unknown
- 2015-08-18 CL CL2015002309A patent/CL2015002309A1/es unknown
- 2015-08-20 ZA ZA2015/06050A patent/ZA201506050B/en unknown
-
2017
- 2017-05-03 CY CY20171100483T patent/CY1118883T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1561336A (zh) * | 2001-10-04 | 2005-01-05 | H·隆德贝克有限公司 | 作为血清素再摄取抑制剂的苯基哌嗪衍生物 |
| WO2007144005A1 (en) * | 2006-06-16 | 2007-12-21 | H. Lundbeck A/S | 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| WO2010094285A1 (en) * | 2009-02-17 | 2010-08-26 | H. Lundbeck A/S | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
Non-Patent Citations (1)
| Title |
|---|
| 氢溴酸沃替西汀合成路线图解;张辉 等.;《江西化工》;20150831(第4期);31-33 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104995181B (zh) | 沃替西汀生产方法 | |
| JP5604424B2 (ja) | アポトーシス促進剤ａｂｔ−２６３の調製のための方法 | |
| CN104011034A (zh) | 用于生产1-[2-(2,4-二甲基-苯基硫烷基)-苯基]-哌嗪的方法 | |
| CN112574196A (zh) | 调节激酶的1H-吡咯并[2,3-b]吡啶衍生物的合成 | |
| TW201033181A (en) | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine | |
| CN101993405B (zh) | 吲哚啉衍生物、及其制备方法和用途 | |
| TW201028383A (en) | Methods of preparing quinoline derivatives | |
| WO2015188686A1 (zh) | 塞瑞替尼及其中间体的制备方法 | |
| JP2016509042A5 (https=) | ||
| JP2000063334A (ja) | エンイン誘導体の新規製造中間体及びその製造法 | |
| JP2014524438A (ja) | インデノピリジン誘導体 | |
| CN104628676A (zh) | 一种Vortioxetine的制备方法 | |
| US20180072690A1 (en) | Methods for Making Serotonin Reuptake Inhibitors | |
| CN110668952A (zh) | 一种盐酸苄非他明的制备方法 | |
| CN105732445B (zh) | 达泊西汀中间体及其制备方法 | |
| HK1216098B (en) | Vortioxetine manufacturing process | |
| NZ710779A (en) | Vortioxetine manufacturing process | |
| OA17454A (en) | Vortioxetine manufacturing process. | |
| TWI247735B (en) | New process for the preparation of a biphenyl ether compound | |
| NZ710779B2 (en) | Vortioxetine manufacturing process | |
| JP2025083072A (ja) | ボルチオキセチンの製造方法 | |
| WO2012051737A1 (zh) | 西那卡塞及其药用盐的制备方法 | |
| JP2017048131A (ja) | アミノヒドロキシピリジン化合物の製造方法 | |
| JP2007070300A (ja) | ２，５−ジアミノ−１，４−ベンゾキノン及び２，５−ジアミノ−１，４−ベンゼンジオール、およびその塩の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |